RxDoctor Payments Data

Kimberly Comeau, PA

Physician Assistant · Swampscott, MANPI 1568415180

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $80,347 of the $119,694 with a category attached, or 67.1%. 30 manufacturers reported payments, led by Johnson & Johnson at 57.1% of the total. Reporting peaked in 2023 at $36,667 and has fallen 50.1% since, to $18,308 in 2025. Among physician assistant clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$119,694in general payments, 2019–2025

Across 1,245 payments — averaging $96.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$68K
  • Janssen Scientific Affairs, LLC$20K
  • AbbVie$15K
  • Lilly USA, LLC$2K
  • E.r. Squibb & Sons, L.L.C.$2K
  • UCB, Inc.$2K
  • plus $10K from 24 others

What the payments were for

  • Consulting fees$1,3481%
  • Speaking & faculty fees$80,34767%
  • Travel & lodging$13,25111%
  • Food & beverage$23,73720%
  • Education$1,0111%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$119,694 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$47,078
Medicare patients
262
Services billed
1,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab11$146,766
Dupixent PenDupilumab32$115,720
Fluorouracil115$5,792
Acitretin19$5,049
Ivermectin11$3,951
Ketoconazole170$3,479
Clobetasol Propionate47$2,256
Betamethasone Dipropionate66$2,192
Tretinoin24$1,709
Triamcinolone Acetonide90$1,242
Metronidazole26$1,207
Doxycycline Hyclate59$954
Mupirocin72$873
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc32$760
Fluticasone Propionate32$750

Paid to pharmacies, not to this prescriber.

Other physician assistant in Swampscott

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →